SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,480.29 -48.78
( -0.07%)

Global Indices

Nasdaq

51,369.65 -132.86
(-0.26%)

Dow Jones

7,690.99 -13.70
(-0.18%)

Hang Seng

66,863.07 1,381.80
(2.11%)

Nikkei 225

10,610.72 -25.99
(-0.24%)

Forex

USD-INR

95.96 0.17
(0.18%)

EUR-INR

109.15 0.06
(0.06%)

GBP-INR

127.16 0.33
(0.26%)

JPY-INR

0.61 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Srestha Finvest Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

539217

INE606K01049

0.8383481

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

45.84

EPS(TTM)

Face Value()

Div & Yield %

Back

piramal capital & housing finance ltd

Natco Pharma announces conclusion of USFDA inspection of its Visakhapatnam unit

Aug 22,2026

Natco Pharma announced conclusion of US FDA Inspection at its Visakhapatnam, Andhra Pradesh, Finished Dosage Formulations (FDF) Unit. The inspection was conducted from 17 August to 21 August 2026.

Upon conclusion of the inspection, the Company has been issued a Form 483 with 4 (Four) observations.

72,480.29 -48.78 ( -0.07%)

51,369.65 -132.86 (-0.26%)

7,690.99 -13.70 (-0.18%)

66,863.07 1,381.80 (2.11%)

10,610.72 -25.99 (-0.24%)

95.96 0.17 (0.18%)

109.15 0.06 (0.06%)

127.16 0.33 (0.26%)

0.61 0.00 (0.14%)